By Eric Ruderman, MD Should I, or shouldn’t I? That is the question. Actually, this question about getting a vaccine is asked by hundreds of patients as we enter the peak flu season. Moreover, aside from the flu vaccine, patients with a compromised immune system need to know about…...
Study Enrolling Patients to Evaluate Efficacy and Safety of Sarilumab in Patients with Giant Cell Arteritis
Primary Objective: To evaluate the efficacy of Sarilumab in patients with giant cell arteritis (GCA) as assessed by the proportion of patients with sustained remission for Sarilumab compared to placebo, in combination with a corticosteroid (CS) tapering course. Secondary Objective: To demonstrate the efficacy of Sarilumab in patients with GCA…...
Patient Advocates Warn Against New Insurance and Pharmacy Benefit Manager Policy That Increases Patient Out-of-Pocket Drug Costs Posted
By Christina Jensen As Open Enrollment Begins, Beneficiaries who Rely on Copay Coupons Must Consider this New Policy When Selecting a Health Plan The AIDS Institute, Arthritis Foundation, and National Organization for Rare Disorders (NORD) hosted a press briefing on a harmful new health insurance and Pharmacy Benefit Manager…...
Computer Technology to Help Diagnose Vasculitis Earlier? Rheumatologist Antoine Sreih, MD is Working On It.
By Ed Becker, Director of Marketing and Communications Despite advances made in the research, understanding, and treatment of vasculitis, the reality is that delay of diagnosis continues to be a critical issue. As a rheumatologist, Antoine Sreih, MD, says that every day he sees the unfortunate result when patients are…...
Vasculitis Foundation Board Welcomes New Members During Its Fall 2018 Meeting
l-r: Suzanne DePaolis, Peter Grayson, MD, Jason Springer, MD, George Casey, Karen Hirsch, Rhonda Johnson Byrd, Victor James, and Don Nagle By Ed Becker The VF held its annual membership meeting on Thursday, October 18, 2018 in Chicago. Karen Hirsch, VF President, reported on the organization’s accomplishments and recognized…...
